• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SNT 25.4% 8.4¢

SYNTARA LIMITED

Syntara Limited is an Australia-based clinical-stage drug development company. The... Syntara Limited is an Australia-based clinical-stage drug development company. The Company is targeting extracellular matrix dysfunction with its amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The Company’s lead candidate SNT-5505 is for the bone marrow cancer myelofibrosis which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its product candidate, SNT-4728, is an inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis and cardiac fibrosis.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
SNT
Chart
08:10 42 18K
08:10 Last post  NZ Trader Comments Created with Sketch.  42  Views Created with Sketch.  18K 
SNT 28/12/24 49 18K
28/12/24 Last post  Mickey Mouse Comments Created with Sketch.  49  Views Created with Sketch.  18K 
SNT
SNT - Media thread
2
27/12/24 68 27K
27/12/24 Last post  Leabeg Comments Created with Sketch.  68  Views Created with Sketch.  27K 
SNT 23/12/24 0 538
23/12/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  538 
SNT 19/12/24 3 1.3K
19/12/24 Last post  Duke2 Comments Created with Sketch.  3  Views Created with Sketch.  1.3K 
SNT 19/12/24 0 270
19/12/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  270 
SNT
Great interview with Syntara CEO Gary Phillips
19/12/24 12 3.8K
19/12/24 Last post  NZ Trader Comments Created with Sketch.  12  Views Created with Sketch.  3.8K 
SNT 18/12/24 18 5.9K
18/12/24 Last post  Mpk888 Comments Created with Sketch.  18  Views Created with Sketch.  5.9K 

See All Discussions arrow Created with Sketch.

Timeline

Change in substantial holding
23 Dec 15:45
 
Section 708A(5)(e) notice
19 Dec 09:17
 
Application for quotation of securities - SNT
19 Dec 09:12
 
Proposed issue of securities - SNT
12 Dec 10:24
 
Proposed issue of securities - SNT
12 Dec 10:00
 
Equity Raising Presentation
12 Dec 10:00
 
View More arrow Created with Sketch.
(20min delay)
Last
8.4¢
Change
0.017(25.4%)
Mkt cap ! $132.6M
Open High Low Value Volume
6.7¢ 8.4¢ 6.7¢ $1.060M 13.73M

Buyers (Bids)

No. Vol. Price($)
2 261913 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 127026 2
View Market Depth
Last trade - 16.10pm 27/12/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.